CD4 and prostate carcinoma: Moreover, patients with prostate cancer showed higher levels of LOY in granulocytes and CD4 + T lymphocytes, suggesting that these cells, when affected by LOY, might convey an increased risk of cancer, and this finding motivated the current study9.